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Abstract
Background: In children with cystic fibrosis there is a decrease in peak work capacity and oxygen consumption on maximal
exercise testing when compared to controls. Previous studies have shown that peripheral muscle force is decreased in children
with cystic fibrosis even in those with minimal changes in lung function. However, no studies have examined peripheral muscle
strength using isokinetic dynamometry which permits measurement of muscle strength throughout range and is considered the
gold standard in orthopaedics and sports medicine. Methods: Isokinetic muscle strength was measured in the knee flexors and
extensors and shoulder flexors and extensors at two speeds of movement in children with cystic fibrosis and matched controls.
Activity levels in both groups were calculated. Results: Thirteen subjects and 13 age and height matched controls were assessed.
Average peak torque was calculated and expressed in terms of body weight. There was a significant difference in peak torquey
body weight in children with cystic fibrosis when compared to controls. FEV1 was significantly correlated with knee muscle
strength and shoulder flexion at 908ys in subjects with CF. Conclusion: Children with CF had lower muscle strength than control
subjects. Airflow limitation was associated with decreased muscle strength. The relationship between muscle strength and exercise
tolerance requires investigation.
 2002 European Cystic Fibrosis Society. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Peripheral muscle strength in patients with chronic
obstructive airways disease has been shown to be
decreased and furthermore, this decreased muscle
strength can contribute to exercise limitation. It is
unclear however, whether patients with cystic fibrosis
demonstrate similar muscle weakness. Studies by Lands
et al. w1x and De Meer et al. w2x have demonstrated
peripheral muscle weakness but Hanning et al. w3x and
Alison et al. w4x showed no difference in peripheral
muscle strength compared to controls. De Jong et al. w5x
found peripheral muscle strength was reduced in patients
with CF who had airflow obstruction and the relationship
was significant when FEV1 was correlated with percent
predicted knee extensor strength and percent predicted
elbow flexor strength. Lands et al. found an association
with reduced nutritional status and muscle strength w6x
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The above studies differed in the peripheral muscles
used for testing and in the methods used to assess
muscle strength; Lands et al. w1x used work output
during a 10 s sprint on an isokinetic cycle ergonometer
as a measure of muscle strength whereas De Meer w2x
examined isometric muscle strength in the shoulder
abductors, elbow flexors, wrist extensors, hip and knee
extensors and ankle dorsiflexors. De Jong et al. w5x
measured peripheral maximal voluntary isometric mus-
cle force of the knee extensors and elbow flexors using
a handheld dynamometer. The muscles examined by
Hanning et al. w3x were elbow flexors, knee extensors
and ankle plantar flexors with grip strength examined
by Alison et al. w4x.
Isometric muscle testing only provides information
on a muscle contraction at a particular angle of the
range of motion of the muscle and therefore may not be
representative of the maximal strength of a muscle or
muscle group. Isokinetic testing however permits the
examination of muscle strength throughout the range of
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movement and provides a measurement of maximal
muscle strength no matter where in the range of motion
this occurs. This method of testing is used extensively
in the orthopaedic and sports arena as a valid and
repeatable method of assessing muscle strength w7x. A
form of isokinetic testing was carried out by Lands et
al. w1x but the use of work output during a 10 s sprint
on a cycle ergonometer may not be truly representative
of muscle strength as factors such as anaerobicyaerobic
capacity and muscular endurance may have affected the
testing.
Barry w8x examined respiratory and peripheral muscle
strength in adults with cystic fibrosis and found that
steroid dose in the previous 2 years was the most
significant predictor of peripheral muscle dysfunction.
Theoretically more active children may have increased
peripheral muscle strength compared to those less active.
In children with cystic fibrosis conflicting findings have
been reported as regards activity levels. Britto et al. w9x
in North Carolina found that physical activity levels in
adolescents with CF did not differ significantly from
their peers. In contrast Nixon et al. w10x in Pittsburgh
found that children with CF engaged in less vigorous
physical activities than their healthy non-CF peers. In
an Irish study Hussey et al. w11x found that adolescents
with CF spend less time than their peers involved in
regular exercise.
The purpose of this study was to compare peripheral
muscle strength in children and adolescents with cystic
fibrosis to matched controls using isokinetic testing. The
relationship between muscle strength and lung function
and body mass index was investigated. In addition
activity levels for both groups were compared and
steroid use in the cystic fibrosis group documented.
2. Materials and methods
Only male subjects were included in this study. The
subjects were recruited from patients attending the out-
patient clinic in AMNCH and the matched controls were
students attending a local school. Exclusion criteria were
2a FEV1 of less than 50% predicted, severe cardiac
disease and musculoskeletal injury or disease affecting
the upper and lower limbs. Ethical permission was
obtained from the hospital ethics committee and written
informed consent was obtained from parents. Age, FEV1
and anthropometrical data of height and weight were
recorded. The subjects in the control group were
matched for age and height.
The muscle groups selected for testing were the knee
flexors and extensors and the shoulder flexors and
extensors. Two speeds of contraction were used 30 and
908ys. As weight was not used to match the subjects
the percentage peak torque divided by the body weight
(Peak torqueybody weight) was the main variable com-
pared between the cystic fibrosis group and the controls.
The value of peak torqueybody weight for each muscle
group at each speed of contraction was an average of
the right and left limbs and this was the value used for
comparison. Therefore eight values in total were calcu-
lated for each subject; knee flexors at 30 and 908ys,
knee extensors at 30 and 908ys, shoulder flexors at 30
and 908ys and shoulder extensors at 30 and 908ys. Two
tailed student t-tests (matched pairs) were used to
compare peak torqueybody weight between the two
subject groups. Pearson product moment was used to
investigate the correlation between muscle strength and
both BMI and FEV1.
The apparatus used for the study was a Biodex III
isokinetic dynanometer. (Biodex Corporation). As this
apparatus was designed for adult use special paediatric
attachments were obtained from the manufacturers and
were required by some of the subjects. For both upper
and lower limb testing the subjects were seated and
belts were attached around the chest and waist to isolate
the muscle group contraction required.
The lower limb testing required the subjects to kick
out their leg against the dynamometer arm from a
position of 908 flexion to a position of full extension
and immediately pull their leg back to the original
starting position. This was repeated five times with each
repetition commencing as soon as the previous repetition
had finished. A one-minute rest period followed and the
process repeated at 908ys. The subject then had a 10-
min rest period while the dynamometer was positioned
for the other leg. During testing all subjects kept their
arms by their side and their other leg was secured using
a belt attached around the thigh.
The upper limb testing also consisted of five repeti-
tions with the subject moving their arm against the
dynamometer with the elbow extended at all times from
a position of 908 shoulder flexion to full elevation and
back to the original position. As before the next repeti-
tion commenced immediately and similar rest periods to
the lower limb testing were used. When one arm was
being tested the other arm remained at their side.
Activity levels for each child was assessed using a
questionnaire. The Questionnaire was the ‘Modifiable
Activity Questionnaire for Adolescents’w12x. The repro-
ducibility and validity of the original questionnaire was
established by Aaron et al. w12x The first question.
sought information on the amount of times in the
previous 2 weeks that the child had participated in at
least 20 min of hard exercise with hard exercise defined
as exercise that made the child breathe heavily and their
heart beat fast. Information on the amount of times in
the previous 2 weeks that the child had participated in
at least 20 min of light exercise was sought in the
second question. Light exercise was defined as exercise
that did not make the child breathe heavily or their heart
beat fast. The third and fourth questions dealt with the
number of hours per day that the child spent watching
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Table 1
Anthropometric data and activity levels in both groups and pulmonary function data in the cystic fibrosis subjects
Cystic fibrosis subjects Controls
Age mean (S.D.) 13.03 (4.66) years 13.23 (3.58) years
Height mean (S.D.) 154.9 (31.8) cm 155.2 (21.9) cm
Weight mean (S.D.) 45.26 (15.4) 42.45 (17.0)
BMI mean (S.D.) 18.28 (2.869) 17.79(1.29)
FEV1% pred mean (S.D.) 82.5 (20.11)
Mean activity level in 27 65
METyhryweek
Table 2
Upper limb peak torqueybody weight
Flexion Extension Flexion Extension
308ys 308ys 908ys 908ys
shoulder shoulder shoulder shoulder
Cystic fibrosis 139% (35.1) 46.2%(19.1) 138% (32.9) 47% (29.6)
mean (S.D.)
ns13
Matched 130% (40.2) 64.3 (28.9) 130% (43.9) 58% (28.3)
controls
mean (S.D.)
Ns13
Difference 9% (y0.066, 18% (y0.028, 8% (y0.067, 11% (y0.06,
between groups 0.25) 0.39) 0.227) 0.28)
and 95%
confidence
intervals
P value Ps0.55 Ps0.03 Ps0.61 Ps0.4
television, videos or playing computer games and the
number of competitive activities the child participated
in.
The final question sought to estimate a value of the
energy expended in regular activities each week. For
each activity the number of months that the activity was
performed over the year, the average number of days
per week of the activity and the average minutes per
day of the activity were ascertained. Using the above
information a value for the hours per week spent at each
activity was calculated.
E.g.: For each activity,
Ž .M= 4.3 weeksymonth =D=N
Hours per weeks
Ž .Ž .60 minyh 52 weeksyyear
Where M is the number of months, D is the number
of days per week and N is the number of minutes per
day.
An estimate for energy expended in regular activities
each week i.e. METsyhryweek was determined by mul-
tiplying the hours per week spent at each activity by the
metabolic cost of each activity in METs w13x.
Medical charts of all patients with cystic fibrosis were
checked to determine if subjects had been on systemic
or inhaled steroids at any point in the previous two
years.
Data was entered into Excel and Pearson correlations
were done with the Minitab statistics package. The study
had an 80% power with a 5% significance level with
13 subjects to detect a correlation of 0.7 or above.
3. Results
Thirteen subjects with cystic fibrosis matching the
criteria were recruited and a corresponding number in
the control group. The mean ages, heights, weights,
BMI, activity levels of the two subject groups and FEV1
of the subjects with cystic fibrosis are presented in Table
1.
Table 2 illustrates the peak torqueybody weight for
the shoulder extensors and flexors at the two speeds of
contraction in the two groups of subjects. Statistical
analysis revealed a significant difference (Ps0.02)
between the two groups for the knee flexors at 308ys.
All other comparisons were non-significant.
Table 3 illustrates the peak torqueybody weight for
the knee flexors and extensors at the two speeds of
contraction in the two subject groups. Statistical analysis
revealed a significant difference (Ps0.03) between the
two groups for the shoulder extensors at 308ys.
Activity levels for both groups were compared in
terms of above. For participation in hard activity for at
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Table 3
Lower limb peak torqueybody weight
Flexion Extension Flexion Extension
308ys 308ys 908ys 908ys
knee knee knee knee
Cystic fibrosis 88.9% (34.3) 219% (87.8) 84.4% (66.3) 165% (48)
mean (S.D.)
ns13
Matched 106% (26.8) 234% (71.5) 85.3% (26.8) 185% (59.6)
controls
mean (S.D.)
Ns13
Difference 17.1% (y0.034, 15% (y0.044, 0.9% (y0.051, 20% (y0.0156,
between groups 0.376) 0.344) 0.025) 0.416)
and 95%
confidence
intervals
P value Ps0.02 Ps0.41 Ps0.93 Ps0.37
Table 4
Correlation between BMI and upper limb peak torque in subjects with
cystic fibrosis
Shoulder flexion at 308ys Rs0.527, Ps0.06 ns13
Shoulder extension at 308ys Rsy0.025, Ps0.93 ns13
Shoulder flexion at 908ys Rs0.538, Ps0.058 ns13
Shoulder extension at 908ys Rsy0.13, Ps0.63 ns13
Table 5
Correlation between BMI and lower limb peak torque in subjects with
cystic fibrosis
Knee flexion at 308ys Rs0.55, Ps0.049
Knee extension at 308ys Rs0.539, Ps0.05
Knee flexion at 908ys Rs0.505, Ps0.07
Knee extension at 908ys Rs0.536, Ps0.05
Table 6
Correlation between FEV1 and peak torque in the upper limbs in
subjects with cystic fibrosis
Shoulder flexion at 308ys Rs0.422, Ps0.15
Shoulder extension at 308ys Rs0.39, Ps0.18
Shoulder flexion at 908ys Rs0.501, Ps0.08
Shoulder extension at 908ys Rs0.27, Ps0.364
Table 7
Correlation between FEV1 and peak torque in the lower limbs in
subjects with cystic fibrosis
Knee flexion at 308ys Rs0.523, Ps0.06
Knee extension at 308ys Rs0.721, Ps0.005a
Knee flexion at 908ys Rs0.65, Ps0.016
Knee extension at 908ys Rs0.727, Ps0.005a
Power of 80% for the number of subjects in the study.a
least 20 min it was found that 75% of both groups
engaged in at least 20 min of hard exercise three or
more times per week. In terms of light exercise all of
the controls and 75% of the CF group reported partici-
pation three or more times per week. Controls spent
more hours per day sedentary in front of TVyVideo.
Energy expenditure in regular activity as measured by
METs was compared to peak torque for each muscle
group studied for both groups and no correlations were
found. However, the mean energy expenditure in regular
activity for the group with CF was lower than the
control group (Table 1).
Only three of the subjects with cystic fibrosis had
been on steroids in the previous 2 years. In each case
of the three cases alternate day steroids had been
prescribed.
BMI was found to be significantly correlated with
measures of knee extensor muscle strength and shoulder
flexor strength at 908ys (see Tables 4 and 5).
A mean FEV1 of 82.5% predicted would reflect mild
disease. The group of patients with cystic fibrosis
demonstrated a wide range of severity based on FEV1
values which ranged from 52% predicted to 114%
predicted. FEV1 was significantly correlated with both
measures of knee extensor muscle strength. A strong
correlation between FEV1 and knee extensor strength at
both speeds was found (Ps0.005) (see Tables 6 and
7). This would have given a power of 0.8 for the
number of subjects in this study.
4. Discussion
Compared to healthy controls children with cystic
fibrosis were found to have a decrease in peripheral
muscle strength in some muscle groups. The difference
appears to be less than that suggested by others w2x and
only statistically significant in the knee flexors and
shoulder extensors at the slower speed of contraction
(308ys). No difference was seen in the shoulder flexors
and knee extensors. The results of this study cannot be
compared directly to the findings of de Meer et al. w2x
or de Jong et al. w5x due to the difference in the
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measurement tool used. De Jong et al. w5x compared
their data on muscle strength to normative data on
isometric muscle strength. Unfortunately there is no
normative data on isokinetic muscle strength in children
and therefore in this study subjects were matched with
healthy controls. De Meer et al. w2x and de Jong et al.
w5x measured isometric muscle strength using a hand
held myometer whereas this study measured muscle
strength using the isokinetic dynamometer.
In contrast to the study by Barry et al. w8x few of the
subjects with CF had received steroids and therefore no
comparison could be made with muscle strength and
steroid dose. Mean BMI was similar to the control
subjects and only slightly less than subjects in de Jongs
study whose mean age was greater at 19 years w5x.
Both FEV1 and BMI were found to be correlated
with peak torque generated by the knee extensors at
both speeds of contraction With the number of subjects
in the study the correlation between the knee extensors
and FEV1 had a power of 0.8. While other correlations
were significant (such as BMI and shoulder flexion at
908ys) they lacked power due to the limited number of
subjects in the study.
While the mean FEV1 was 82.5% the range was 52–
114% indicating that both mild and moderately severe
subjects were included in the study. The mean body
mass index was 18.3. The range was from 14 to 23.7
indicating a wide spread between those underweight to
those within a normal range. However, the age range
from 8 to 18 and using BMI particularly in this large
age range may not be the most appropriate method of
assessing nutritional status due to different cut-offs for
each chronological age w14x. The sum of skinfold meas-
urements may have been more appropriate as they
provide an estimate of body fat and characterize the
distribution of subcutaneous adipose tissue over the
whole body w15x.
The group studied differs from that of de Jong et al.
w5x in that mean FEV1 in de Jongs group was 20% less
at 62% predicted but mean BMI was higher than at
19.5. While a different method of assessing muscle
strength was used both studies revealed a significant
relationship between FEV1 (percent predicted) and knee
extensor muscle strength. Unlike de Jong et al. w5x but
in agreement with Lands et al. w6x a moderate correlation
between muscle strength and nutritional status as meas-
ured by BMI was found.
Reduced participation in regular activity was seen in
the cystic fibrosis group when compared to controls but
no relationship between this participation and peak
torque was found in either the CF or the control group.
This measurement of participation may have to be
interpreted with caution as self-report on activity levels
is based on the child’s subjective evaluation of the
frequency and duration of their regular activities. It does
not permit measurement of intensity of activity.
The questionnaire investigated regular physical activ-
ity and did not take into account parts of the day when
the child may have been very active in non-organised
play in the school yard, garden, park etc.
The effect of the decrease in muscle strength on
exercise tolerance needs investigation. The effect of
peripheral muscle strengthening programmes and their
functional effect also merits enquiry.
5. Conclusion
There was a difference in muscle strength in some
muscle groups when children with CF were compared
to controls. A strong correlation between knee extensor
muscle strength and FEV1 was found and a moderate
correlation between BMI and knee extensor muscle
strength was seen. Despite a lower level of activity
being seen in children with cystic fibrosis, activity was
not found to be related to muscle strength in either
group. However, more objective methods of assessing
activity, which could include intensity of, may be indi-
cated. The effect of reduced muscle strength on exercise
tolerance needs to be investigated as does the effects of
peripheral muscle strengthening programmes in subjects
with CF.
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